Related Experiment Video
Updated: Jun 23, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Ferrous sulfate versus iron polymaltose complex for treatment of iron deficiency anemia in children
Ankur Vikas Bopche1, Rashmi Dwivedi, Rakesh Mishra
1Department of Pediatrics, Kamla Nehru Hospital, Gandhi Medical College and Associated Hamidia Hospital, Bhopal, MP, India.
Insights
Ferrous sulfate showed better clinical response and fewer side effects than iron polymaltose complex in treating pediatric iron deficiency anemia. This finding aids in selecting optimal iron therapy for children.
Area of Science:
- Pediatric Hematology
- Clinical Nutrition
- Pharmacology
Background:
- Iron deficiency anemia (IDA) is a prevalent nutritional disorder in children.
- Effective iron supplementation is crucial for managing pediatric IDA.
- Comparing different oral iron formulations is important for optimizing treatment outcomes.
Purpose of the Study:
- To compare the clinical response and side effects of Ferrous sulfate (FS) and Iron polymaltose complex (IPC) in children with IDA.
- To evaluate the efficacy and tolerability of two common oral iron therapies.
Main Methods:
- A randomized controlled trial involving 118 children diagnosed with IDA.
- Participants were assigned to receive either oral IPC or oral FS (6 mg/kg/day elemental iron, divided doses).
- Clinical response (hemoglobin levels) and residual complaints were assessed in 106 followed-up children.
Main Results:
- Children treated with Ferrous sulfate exhibited higher hemoglobin levels compared to those receiving Iron polymaltose complex.
- The Ferrous sulfate group reported fewer residual complaints.
- Adverse effects were less significant in the Ferrous sulfate group.
Conclusions:
- Ferrous sulfate demonstrates a superior clinical response in treating pediatric iron deficiency anemia.
- Ferrous sulfate is associated with fewer adverse effects compared to Iron polymaltose complex in this pediatric population.
- These findings suggest Ferrous sulfate as a potentially more effective oral iron therapy for children with IDA.
Abstract:
We assessed the clinical response and side effects of Ferrous sulfate (FS) and Iron polymaltose complex (IPC) in 118 children with Iron deficiency anemia (IDA). Subjects were randomized to receive therapy with either oral IPC (Group A, n=59) or oral FS (Group B, n=59); all were given elemental iron in three divided doses of 6 mg/kg/day. One hundred and six children could be followed up; 53 in each group. Children who received ferrous sulfate were having higher hemoglobin level, and less residual complaints as compared to those who had received iron polymaltose complex. Our study suggests ferrous sulfate has a better clinical response and less significant adverse effects during treatment of IDA in children.
Related Concept Videos
Antiprotozoal Agents
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Formation of Complex Ions
Precipitation and Co-precipitation
Extraction: Advanced Methods
Complexometric Titration: Overview

